Pharmyn ApS: Financial statements 2024
CVR: 37133892
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 6,544 and a net result of DKK 6,701 compared with DKK 10,429 the year before. That is a decrease of 37.4% compared with the year before. Equity in the 2024 report amounted to DKK 31,071. The solvency ratio was 83.8%.
- Gross Profit
- DKK 6,544
- Profit/Loss
- DKK 6,701
- Equity
- DKK 31,071
- Total Assets
- DKK 37,071
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 7 t. | 7 t. | 31 t. | 0 |
| 2023 | - | 10 t. | 10 t. | 24 t. | 0 |
| 2022 | - | -20 t. | -20 t. | 14 t. | 0 |
| 2021 | - | 12 t. | 12 t. | 34 t. | 0 |
| 2020 | - | -20 t. | -21 t. | 22 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharmyn ApS has published its annual report for 2023. Gross profit came to DKK 10,454, and the net result was DKK 10,429.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662.